CENCORA INC (ABG.DE) Stock Fundamental Analysis
Europe - FRA:ABG - US03073E1055 - Common Stock
245 EUR
-0.5 (-0.2%)
Taking everything into account, ABG scores 5 out of 10 in our fundamental rating. ABG was compared to 29 industry peers in the Health Care Providers & Services industry. ABG has an average financial health and profitability rating. ABG is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ABG was profitable.
ABG had a positive operating cash flow in the past year.
Of the past 5 years ABG 4 years were profitable.
Each year in the past 5 years ABG had a positive operating cash flow.
1.2 Ratios
ABG's Return On Assets of 2.57% is in line compared to the rest of the industry. ABG outperforms 58.62% of its industry peers.
Looking at the Return On Equity, with a value of 95.81%, ABG belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ABG has a Return On Invested Capital of 13.52%. This is amongst the best in the industry. ABG outperforms 96.55% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABG is significantly above the industry average of 6.09%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.57% | ||
| ROE | 95.81% | ||
| ROIC | 13.52% |
ROA(3y)2.68%
ROA(5y)0.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.51%
ROIC(5y)15.55%
1.3 Margins
ABG has a Profit Margin of 0.60%. This is in the lower half of the industry: ABG underperforms 68.97% of its industry peers.
ABG's Profit Margin has improved in the last couple of years.
The Operating Margin of ABG (1.09%) is worse than 79.31% of its industry peers.
ABG's Operating Margin has been stable in the last couple of years.
ABG's Gross Margin of 3.40% is on the low side compared to the rest of the industry. ABG is outperformed by 75.86% of its industry peers.
ABG's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.09% | ||
| PM (TTM) | 0.6% | ||
| GM | 3.4% |
OM growth 3Y-6.12%
OM growth 5Y-0.1%
PM growth 3Y-10.65%
PM growth 5Y1.52%
GM growth 3Y1.72%
GM growth 5Y3.69%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ABG is creating value.
ABG has less shares outstanding than it did 1 year ago.
ABG has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ABG has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.95 indicates that ABG is not in any danger for bankruptcy at the moment.
ABG has a Altman-Z score of 4.95. This is amongst the best in the industry. ABG outperforms 93.10% of its industry peers.
The Debt to FCF ratio of ABG is 7.22, which is on the high side as it means it would take ABG, 7.22 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.22, ABG is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
ABG has a Debt/Equity ratio of 4.06. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ABG (4.06) is worse than 79.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.06 | ||
| Debt/FCF | 7.22 | ||
| Altman-Z | 4.95 |
ROIC/WACC1.57
WACC8.61%
2.3 Liquidity
ABG has a Current Ratio of 0.90. This is a bad value and indicates that ABG is not financially healthy enough and could expect problems in meeting its short term obligations.
ABG's Current ratio of 0.90 is in line compared to the rest of the industry. ABG outperforms 48.28% of its industry peers.
A Quick Ratio of 0.53 indicates that ABG may have some problems paying its short term obligations.
With a Quick ratio value of 0.53, ABG is not doing good in the industry: 75.86% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
ABG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.64%, which is quite good.
ABG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.21% yearly.
The Revenue has grown by 11.56% in the past year. This is quite good.
ABG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.36% yearly.
EPS 1Y (TTM)16.64%
EPS 3Y14.11%
EPS 5Y14.21%
EPS Q2Q%19.76%
Revenue 1Y (TTM)11.56%
Revenue growth 3Y11.16%
Revenue growth 5Y10.36%
Sales Q2Q%8.65%
3.2 Future
Based on estimates for the next years, ABG will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.69% on average per year.
ABG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.48% yearly.
EPS Next Y17.02%
EPS Next 2Y13.19%
EPS Next 3Y12.22%
EPS Next 5Y11.69%
Revenue Next Year9.7%
Revenue Next 2Y8.07%
Revenue Next 3Y7.56%
Revenue Next 5Y7.48%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 18.66, which indicates a rather expensive current valuation of ABG.
ABG's Price/Earnings is on the same level as the industry average.
ABG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.41.
Based on the Price/Forward Earnings ratio of 16.39, the valuation of ABG can be described as correct.
ABG's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ABG is more expensive than 62.07% of the companies in the same industry.
ABG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.66 | ||
| Fwd PE | 16.39 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ABG is valued a bit more expensive than the industry average as 72.41% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABG indicates a slightly more expensive valuation: ABG is more expensive than 75.86% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 49.07 | ||
| EV/EBITDA | 13.63 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ABG may justify a higher PE ratio.
ABG's earnings are expected to grow with 12.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.1
PEG (5Y)1.31
EPS Next 2Y13.19%
EPS Next 3Y12.22%
5. Dividend
5.1 Amount
With a yearly dividend of 0.76%, ABG is not a good candidate for dividend investing.
ABG's Dividend Yield is comparable with the industry average which is at 2.66.
With a Dividend Yield of 0.76, ABG pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.76% |
5.2 History
The dividend of ABG has a limited annual growth rate of 5.42%.
Dividend Growth(5Y)5.42%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
ABG pays out 22.69% of its income as dividend. This is a sustainable payout ratio.
ABG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.69%
EPS Next 2Y13.19%
EPS Next 3Y12.22%
FRA:ABG (9/22/2025, 7:00:00 PM)
245
-0.5 (-0.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.56%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap47.50B
Analysts79.09
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.76% |
Yearly Dividend1.79
Dividend Growth(5Y)5.42%
DP22.69%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.88%
Min EPS beat(2)3.15%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)4.45%
Min EPS beat(4)2.68%
Max EPS beat(4)6.6%
EPS beat(8)8
Avg EPS beat(8)4.51%
EPS beat(12)12
Avg EPS beat(12)3.81%
EPS beat(16)15
Avg EPS beat(16)3.45%
Revenue beat(2)0
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.35%
Revenue beat(4)2
Avg Revenue beat(4)0.52%
Min Revenue beat(4)-1.29%
Max Revenue beat(4)2.93%
Revenue beat(8)5
Avg Revenue beat(8)0.6%
Revenue beat(12)8
Avg Revenue beat(12)0.97%
Revenue beat(16)10
Avg Revenue beat(16)0.83%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.66 | ||
| Fwd PE | 16.39 | ||
| P/S | 0.18 | ||
| P/FCF | 49.07 | ||
| P/OCF | 32.16 | ||
| P/B | 28.29 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.63 |
EPS(TTM)13.13
EY5.36%
EPS(NY)14.95
Fwd EY6.1%
FCF(TTM)4.99
FCFY2.04%
OCF(TTM)7.62
OCFY3.11%
SpS1384.93
BVpS8.66
TBVpS-71.18
PEG (NY)1.1
PEG (5Y)1.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.57% | ||
| ROE | 95.81% | ||
| ROCE | 17.33% | ||
| ROIC | 13.52% | ||
| ROICexc | 15.22% | ||
| ROICexgc | N/A | ||
| OM | 1.09% | ||
| PM (TTM) | 0.6% | ||
| GM | 3.4% | ||
| FCFM | 0.36% |
ROA(3y)2.68%
ROA(5y)0.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.51%
ROIC(5y)15.55%
ROICexc(3y)21.56%
ROICexc(5y)21.55%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.17%
ROCE(5y)19.93%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.26%
ROICexc growth 5Y0.87%
OM growth 3Y-6.12%
OM growth 5Y-0.1%
PM growth 3Y-10.65%
PM growth 5Y1.52%
GM growth 3Y1.72%
GM growth 5Y3.69%
F-Score6
Asset Turnover4.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.06 | ||
| Debt/FCF | 7.22 | ||
| Debt/EBITDA | 1.77 | ||
| Cap/Depr | 55.39% | ||
| Cap/Sales | 0.19% | ||
| Interest Coverage | 10.99 | ||
| Cash Conversion | 38.29% | ||
| Profit Quality | 60.17% | ||
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z | 4.95 |
F-Score6
WACC8.61%
ROIC/WACC1.57
Cap/Depr(3y)53.4%
Cap/Depr(5y)67.19%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.19%
Profit Quality(3y)175.45%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.64%
EPS 3Y14.11%
EPS 5Y14.21%
EPS Q2Q%19.76%
EPS Next Y17.02%
EPS Next 2Y13.19%
EPS Next 3Y12.22%
EPS Next 5Y11.69%
Revenue 1Y (TTM)11.56%
Revenue growth 3Y11.16%
Revenue growth 5Y10.36%
Sales Q2Q%8.65%
Revenue Next Year9.7%
Revenue Next 2Y8.07%
Revenue Next 3Y7.56%
Revenue Next 5Y7.48%
EBIT growth 1Y19.18%
EBIT growth 3Y4.36%
EBIT growth 5Y10.24%
EBIT Next Year29.96%
EBIT Next 3Y14.19%
EBIT Next 5YN/A
FCF growth 1Y-59.12%
FCF growth 3Y10.42%
FCF growth 5Y8.07%
OCF growth 1Y-46.38%
OCF growth 3Y9.35%
OCF growth 5Y8.25%